Analyzing Extendicare (OTCMKTS:EXETF) and Bioqual (OTCMKTS:BIOQ)

Bioqual (OTCMKTS:BIOQ) and Extendicare (OTCMKTS:EXETF) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation.

Analyst Recommendations

This is a summary of current recommendations and price targets for Bioqual and Extendicare, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bioqual	0	0	0	0	0.00
Extendicare	0	0	5	0	3.00

Earnings & Valuation

This table compares Bioqual and Extendicare”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioqual	$48.87 million	0.59	-$1.05 million	($1.08)	-30.09
Extendicare	N/A	N/A	N/A	($0.26)	-89.65

Extendicare has lower revenue, but higher earnings than Bioqual. Extendicare is trading at a lower price-to-earnings ratio than Bioqual, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

9.4% of Extendicare shares are held by institutional investors. 39.2% of Bioqual shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Bioqual and Extendicare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bioqual	-2.27%	-2.69%	-1.50%
Extendicare	N/A	N/A	N/A

Summary

Extendicare beats Bioqual on 7 of the 10 factors compared between the two stocks.

About Bioqual

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

About Extendicare

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.